<SUBMISSION>
<ACCESSION-NUMBER>0001193125-05-155165
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20050728
<ITEMS>1.01
<ITEMS>9.01
<FILING-DATE>20050802
<DATE-OF-FILING-DATE-CHANGE>20050802
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DAVITA INC
<CIK>0000927066
<ASSIGNED-SIC>8090
<IRS-NUMBER>510354549
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-14106
<FILM-NUMBER>05992995
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
<PHONE>3105362400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE HOLDINGS INC
<DATE-CHANGED>19950524
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE INC
<DATE-CHANGED>19940719
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Date of Report (Date of earliest event reported) July 28, 2005 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>DaVita Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter)
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>1-4034</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>51-0354549</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>601 Hawaii Street, El Segundo, California</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>90245</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Registrant&#146;s
telephone number, including area code (310) 536-2400 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not
applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report.) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;1.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On July 28, 2005, DaVita Inc. (&#147;DaVita&#148;) and Gambro Healthcare, Inc., a Tennessee corporation (&#147;Gambro Healthcare US&#148; and, together
with DaVita, collectively, the &#147;Sellers&#148;) entered into an Asset Purchase Agreement (the &#147;Agreement&#148;) with RenalAmerica, Inc., a Delaware corporation (the &#147;Buyer&#148;) to sell 70 freestanding renal dialysis centers
(collectively, the &#147;Assets&#148;) to the Buyer. The purchase price for the Assets is $320.5 million, subject to post-closing adjustments, payable by the Buyer in cash at the closing. The Buyer has agreed to assume specified liabilities related
to the Assets, and other liabilities will be retained by the Sellers. Completion of the transaction is subject to certain closing conditions, including consummation of DaVita&#146;s acquisition of Gambro Healthcare US. A copy of a relevant press
release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Financial Statements and Exhibits </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Exhibits <B></B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release, dated July 28, 2005</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">- 2 - </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Dated: August 2, 2005 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">/s/ Joseph Schohl</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Joseph Schohl</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Vice President, General Counsel and Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">- 3 - </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>INDEX TO EXHIBITS
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Number</B></FONT><BR><HR WIDTH="42" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P><HR WIDTH="40" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release, dated July 28, 2005</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">- 4 - </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g12521img_12521.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Contact:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">LeAnne Zumwalt</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Investor Relations</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">650 696-8910</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><U>DaVita Announces
Signing Definitive Agreement with RenalAmerica </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">El Segundo, California,
July 28, 2005 &#150; DaVita Inc. (NYSE: DVA), announced today that DaVita and Gambro Healthcare, Inc. have entered into a definitive agreement with RenalAmerica, Inc. to sell 70 freestanding renal dialysis centers to RenalAmerica. The divestiture of
these DaVita and Gambro Healthcare US centers is required by the Federal Trade Commission as part of its review of DaVita&#146;s acquisition of Gambro Healthcare US. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">The purchase price for the centers is $320.5 million, subject to post-closing adjustments, payable by RenalAmerica in cash at closing. As
part of the transaction, RenalAmerica will assume specified liabilities related to the centers and all other liabilities will be retained by DaVita. Completion of the transaction is subject to certain closing conditions, including consummation of
DaVita&#146;s acquisition of Gambro Healthcare US which we currently expect will take place during the next thirty to sixty days. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Kent Thiry, Chairman and CEO of DaVita stated &#147;Divesting units has been a difficult process. We are happy to have found such a high-quality executive team and
primary shareholder to take care of our patients and teammates.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Nashville-based RenalAmerica was founded by its CEO, Michael Klein, who most recently served as a senior executive for Gambro Healthcare US. RenalAmerica has teamed with Welsh, Carson, Anderson &amp; Stowe (WCAS), a private equity investor,
to finance the acquisition of the centers. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">DaVita is a leading provider of
dialysis services for patients suffering from chronic kidney failure. DaVita operates and provides administrative services to kidney dialysis centers and home peritoneal dialysis programs domestically in 37 states, as well as Washington, D.C. As of
June 30, 2005, DaVita operated or provided administrative services at 706 outpatient centers serving approximately 57,200 patients. </FONT></P>


</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g12521img_12521.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g12521img_12521.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1
M````5@````$#!0`!````:`````,#`0`!`````()J`Q!1`0`!`````0```!%1
M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E``"@
MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`%\!!`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?J***`"BBB@`HHHH`*YWQ)XPLO
M#[QVB12W^JS_`.HT^U&Z1_<_W5]S4^L:E>-/_96C*C:BZAGFD&8[5#QO;U;K
MM7OCG`I^A>&K'05EDAWSWLYW7-[.=TLS>I/IZ`<"K22UD0VWHCCW\/>//%9,
MFLZVNA6;$XLM/^:3'HS_`/US]*?%\%O"XRUS)J-U*WWI);GDGUX`KT6BJ]O-
M?#IZ"]E'KJ>8WGP5TI,S:)JNHZ;=#[KB3>!_(_K6&_BKQQ\-KV.W\1I_:VEN
MVU+G.21[/Z_[+5[5574=.M-5L)K*^@2>WE7:Z.,@_P#U_>KC7;TJ:HET4M8:
M,K:#X@TWQ+IJ7^EW`FA;AAT9&_NL.QK3KYYF34_@[XZ5HF>XTJY&<'_EM%GD
M'L'7U_H:]]T^_MM4T^WO[.42VTZ!XW'<&IK4N2THZICIU.;1[HLT445B:A11
M10`4444`%%5-2NFLK"2X4`E,'![\BJ^IZFD&GHT+9FN`!"!UY[UA5Q-.ES<S
MV5_Z^XUA1G.UNKL:=%`Z#-%;F04444`%%%%`!1110`4444`+1110`E4=5&JF
MV4:0UDMQN^8W:LR[?8*0<]*O44T[`SR7QE\1O%'@S48+&YBT6ZEEB\W]TDHV
MC.!G+=\&K_@WQ=XQ\9Z?<7MM#HMK%#+Y7[V.5MQQDXPWN*\I^)VJ?VK\0-4D
M#9C@<6R?1!@_KFO</A=I?]E_#[359<27"FY?ZN<C],5W581A14K:LXZ<I3J-
M7T1/,/'R)F%O#DK?W629/UR:R_\`A8EQHVH1Z;XPTLZ1+,"(;V)_-MW/UZC\
M?QQ7?5S_`(VT*'Q#X1U"RDC#2")I(6QRLBC*D?R^A-<L)1;M)'1*,DKQ9JZ=
M:VUM:@VS"02GS6FSDRD\[B>^?Y8QQ5NO%_@IXOE>1_#%Y(64(9;,L>5Q]Y/I
MW'XU[116ING-Q84YJ<;H****R-`HHHH`Y3XA^%U\4^$[BVC0&]@'G6K=]X_A
M_P"!#(_*O/\`X)>*76:?PQ=,=I#3VN[L1]]/Z_G7M=?-OC.UF\#?%(WUHNV/
MSEO8`.`58_,OY[A]#79A_P!Y!TGZHYJWN251?,^DJ*@LKN*_L8+R!@T,\:R(
MP[@C(J>N,Z0HHHH`*BG69H_W#JD@Y&X9!]C4M%*2NK#3L[G':[>:H5%M>1QQ
M1,<CR^0^/>H=!$$VJ1M=S'<F/*5NY[#/MZ5HW5N^OZQM0D6=O\C/ZGOBM";P
MYITB8CC,+CHZ,<@U\NL%7K8EXB#YHQ>G,][=K>>W0]EXBE3I*E+1M:VZ7-:B
MH;43+;(LY#2J,,P_B]_QJ:OJ(NZ3/&:L[!16;?Z_I6FS0P75]"D\\BQQ0ALN
M[$X`"CFM*JLT3=!1112&%%%%`!1110`M%%%`"54U6^32])O+^3&RVA>4Y_V0
M35NN"^,&J?V=X`N85;$EY(EN/H3N;]%/YU=./--1)G+EBV?/%K#/K&L0P9+3
MWEP%SZL[?_7KZ_MK>.TM(;:(8CB18U'H`,"OFWX2Z4=3^(%FY7,=FK7+^Q`P
MO_CQ%?2]=>.E[RCV.;"1]UR"HKEUCM9G<X548D^@Q4M87C34/[+\%:Q=YP4M
M7"G_`&F&T?J17%%7:1U2=E<^9O"FH'3?&&DWJM@1W:9.<?*6P?T)KZVKX[TF
M)IM8L(4QN>XC49]2PK[$KNQRUBSDPFS"BL+Q/XNTGPE8?:=2GP[?ZJ!.9)3[
M#^IXKCM#U[QIX_WW6GM;Z!HNXJL_EB::3']W=Q^.,?6N2-*37-LCI=1)\O4]
M.HKB+K2/&>BPM?:=XA;6&C&Y[&]MT02J.H5D`(;TKG?$OQF733IQTFQANEN;
M83RB:0JT3$D;"!W&#FJC1E-^YJ)U5'XM#UFO(?CMI(DTW3-71/FAE-O(W^RP
MR/U4_G7H'@[6[SQ%X8M=6O;6.UDN-S+'&Q(V9P#SZXS5'XEZ=_:7P^U:,+N>
M*+STXZ%"&_D#3HMTZJOW%42G3=C*^#FL?VEX&CM7;,MA*T!S_=^\OZ''X5Z#
M7@GP+U0P>([_`$UFPEU;B11GJR'_``8_E7O=&)ARU6*A+FIH****P-@JNTD5
MR9[:.?\`>)@2;#RF><>QQ6/XAUZ2SN+?1],"RZU>@^2A&5A3^*5_]D?J>*EE
ML]1T?0EAT2*&\OMX9VO)2GFL3\[L0#R?\]*IPNM>HN:STZ&O#!';PK%"@1%&
M`!4E>+^*/BQXG\/:I+I4VF:4EW&H+M'(\H7<,CTYQ_.O0/A_>:OJGA.WU/6I
M_-N;QFF4!`H2/HH`'L,_C5O#NG!/1+H0JRG)KJ=17'?%#63HO@*_>-]LUR!;
M1G.#E^#C_@.ZNAUF758K#=HUM;7%WO`V7,IC3;W.0#S7@_Q9U[7+R^L](UFW
MLK=[=3/LM)FD!+<#<2!@@`_G5X>ESS1->?+!D?P;T;^TO'`O9$W16$1E)/\`
M?/RK_,G\*^C*\6^%VG^*]+\.O?:3I>F3PZ@^\275RR/A<J!@*>,Y_.O3=#N/
M$TUQ*-<L=.MH0O[LVL[2,6SWR!@8J\4^:;=]B<.N6"7<W**ANKJ"RM9;JZF2
M&")2\DCG`4#N37F-Q\3]2\2:X-%\#V"3.<[KV[!"*HZMM[#Z]?2L(4Y3V-93
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M&TT$3AK?3U^S(0>"W5S^?'_`:O"0YJB\B,1+EAZE'X9Z6VJ_$#2T"Y2W?[3(
M?0)R/UQ7T7XF\06OAC0+G5;KE8EPD8.#(Y^ZH^IK@/@EX9:QTBXUZX0K+??N
MX`1R(@>OXG^0K)^/&JR&ZTK2%)$01KEQZG.U?RPWYUM5M6Q"CT1E3O2H\W5G
M"6,>I?$;QY"EY*S37<N9&!XBB')"^@`X'O7U!96=OIUE!9VD2Q6\"!(T7H`.
ME>._`C2%+ZKK+KR-MK$?_'F_]EKVFL\7.\^1;(O#1M'F>[$)"J6)``Y)-?).
MH@:]XQNEL5P+^_<0@#L\AQ_.OHOXDZW_`&%X%U&=&VSS)]GB_P!Y^/T&3^%>
M-_!W1CJ?CF*Y9,PZ?&T[9_O'Y5_4Y_"M,+[D)5&1B/>G&!]#Z?91:;IMK8P#
M$5O$L2?11@?RI;^V6]TZYM7`*S1-&0>X((_K5BBN&^MSKMI8^5_`%ZVD?$'2
M78[0+GR'^C90_P`Z^J*^2O$2'2O&NIA,`VU_(RX.<8<D5]7VLZW5G!<+]V6-
M7'T(S7;C5?EEW.7"NUXDU<UXS\86OA#2A.Z&XO9SY=K:J?FE?_`=S^'>K7BK
MQ18>$M%DU&];)^[#"#AI7[*/ZGL*\_\`A[HM_P"+=?D\=>(EW?,1I\)^ZN/X
M@#_".@]3DUSTZ:MSSV7XFTYN_)'<Z_P1X=N]-MIM7UJ0SZ]J.'N9&_Y9+_#$
MOH!Z#O\`05U,LJ00O-(P6.-2S,>P')-/KC/BEK)T;P%?,C;9KK%K'S_?Z_\`
MCH:I5ZD[=RG:$?0^?KN2X\7^,Y'3)FU*\PGL&;`_(8_*OJVRM(K"QM[.`8B@
MC6)!Z!1@?RKY\^#&B_VEXS-\ZYATZ(R<]-[?*O\`[,?PKZ*KIQLO>4%T,,+'
M1R?4"0!D\"OD_P`3ZC)XI\;WMS#EC=W7E0#_`&<A$_0"OHKX@ZS_`&%X'U.[
M5]LS1>3%_OO\HQ],D_A7A_PDT4:MX\MI'7,-BAN6^HX7_P`>(/X4\(N2$JC%
MB/>E&"/HG1]-BT?1K+3H0/+MH5B&.^!U_'K5VBN:^(&JR:-X%U:\A<I-Y/EQ
ML.H9R%!_6N-)SE;N=+:C&_8\7^*7CN7Q'JLFEV4I&DVCE?E/^O<<%CZCT'XU
MZQ\,?"J>&O"D+RQ@7]ZHGN&(Y&?NI^`/YDUX'X*T<:[XQTO3V&8GF#RC_87Y
MF_08_&OK&NW%-4XJE$Y<.G.3J2"O!_CM>02^(=,M$`,\%NS2,.P9N!^A/XU[
MP2`"2<`5\G^)M1F\5>-[VYBRS75UY4`_V<A$'Y`5&"C>?-V+Q4K0MW/9_@KH
MQL/!SZA(F)=0F+@]_+7Y5_7<?QKTFJ6D:=%I&CV>G0_ZNVA6('UP,9J[7-5G
MSS<C:G'EBD+1114%E+5[]-*T:]OY"-MM`\IS[`FODFPMIM:UNVM<EIKVX5"?
M=VY/ZU[_`.,)_%?B+PO=Z39^%;FWDN0JF22[@P%R"1PW?&*X+PCX`\5>'_$]
MGJM[X>DN(K8LXCBNH02V"`>6[9S7H89JG"3;5_5''73G))+0]\AA2W@CAC&V
M.-0BCT`&!4E<Q_PD7B#_`*$R^_\``RW_`/BZJ7WB#QG)$8]-\&E)6X$MW?1;
M%]R%))_.N/V;?;[T=/.OZ3'?$3QE%X2\/R-%(IU*Y!2UCZD'NY'H/YX%>)>`
M/`]WXSU@2SB1=+A?==3D\N>NQ3W)[^F?I7H5I\)M3U[6&U?QKJPN)7ZV]J2!
MCLN[L/8#\:]3L;"UTRRBL[*WC@MXEVI'&,`"NA58T8<L-6^IBZ<JLN:>B1)!
M!%;6\<$$:QQ1*$1%&`J@8`%>'?'>RE37-*OB/W,ENT(/HRMG^35[K6!XP\*V
MOB_0)=-N&\N3/F03`9,;CH?IV(]#6-"IR5%)FE:'/!I&#\';98/AW:N!@SS2
MR-[G=C^2BN]KRKP?>:_X`LGT+6]`O[NT21GMKO3HO/4@\D$#D<Y//K71R>(=
M>U]#:Z#HMYIROP^H:I%Y8B'<K'G<[>F<"JJP<IN73N*G)*"74\X^-OB1+[6+
M;0K:0-'99DGP>/-8<#\!_P"A5U7P1T;['X5N-4=<27\QVDC^!.!^NZL?XA_#
M&>/0]/GT*"6]N+8R&\8_--<%R"9#_>.<\>AXJ_X:U?Q7+X3L?#>D^'+O3KR*
M,0R:A>)LBB7/+J#RS<]/6MY-.@HP?J8Q359RD>E6>KV-_?WUE:S>9/8LJ7``
M.$9AD#/0G'4=JO5E>'=`M?#>D1V%LS2')>:9_OS2'EG;W)K5KAE:^AUJ]M3Y
M:^)<'V?XB:TG'S3!^!_>53_6O</#_BJPTSX6Z5K.I7`2&.U6,]V=U^7:!W)*
MUX[\78UC^)&H;1C='$Q]SL%<_:2:SXD.E>'()'F2)F2UM^BJ6)+,?S/)Z"O5
ME256E"_3_(\]5'3J2L=CIEOJGQ?\<&YO]T6F6W+JGW8H\\1J?[S=S]3V%?05
MO!%:V\=O!&L<,2A$11@*HX`%8_A/PQ:>$]!ATVU`9A\TTN.99#U8_P`A["MR
MN"O54W:.RV.RE3Y5=[L*\,^.NKF75M-T=&^2"(W$@_VF.!^@/YU[G7CGQ;\!
M:QK&L1:UI%NUVIA$4T*$;U*DX(!Z@Y[>E/"N*JIR)Q";IV1N?!?1/[.\&F_D
M7$VHRF3)Z[%^5?ZG\:[1-=L9/$+Z'&SR7D<'GR[%RL:DX`8]B>H'I7$>'+[Q
MO-X<L='M?#D>DO;PK`U_>2#:H`QN6(<D]^>,UVF@:!;:!9O%$\D]Q.YEN;J8
MYDGD/5F/\AT`I5M9.4MRJ?PI(\O^/&JD)I.CHW#%KF09]/E7^;5I?`[1OLOA
MR\U9TQ)>S;$)'\"<<?\``BWY4OQ;\":IXDEL]5TB,7$T$9AEM]P#,N<@KGCN
M>*G\%ZMXCTKPI::(G@V_^VVP*"29UB@.23N+$Y'7D`&MVT\.HQ?J8V:K.4CN
M->UVV\/Z<;J<-)*Y\NWMX^9)Y#T11W)_3K7->/;74M3^%-]]MABCOUA6>:*`
MEE7:P8@$^@'Z5JZ-X<N$U'^VM>NDO=7*E8P@Q#:J>JQ`^O=CR:Z*1$EC:.10
MR,"K*1D$'J*YE)0:MK8Z&G).Y\^_!"W2;QM<3-]Z&R=E^I91_(U]"5X]%X.U
MOX=^,FUK0;&35-'F#)+;0D>;&A.=H!ZX(&"/3!KLAXYEN1Y=AX6U^:Y(^5)[
M3R$S[NQP!6V(_>3YX[&5'W(\LMQGQ-\3)X;\'W)20+>W@-O;C/.2/F;\!^N*
M\:^$NC?VKX\M9&7,-BIN7SZCA?\`QX@_A7J]]X$OO$.FZI=Z[<0RZS=VQAM8
MT&8;)>"%7/4D@9;KZ5POP^.O^!=2U**Z\(:I=S7"I&C0Q\`J3QN^[M.>OM6E
M)Q5*48O4SJ)NI%RV/;+[5[+3;FRMKF;;/>R^3!&%+%VQD\#L!U/05+>:C8Z>
MJM>WEO;*YPIFD"9/MFN;\-:!J3ZI+XD\1LC:M,GEPVT9S'91?W%]6/<US?C_
M`$G4)M>>X%E=3Q2Q@13P0F7:JQR!H<#[I9F4@GCU^[7-&G%RY;F[G)1O8]15
M@RAE(((R".]%8OA*SGL/#-K;W$#V[!I&2!VW-#&TC-&A/JJ%5]L45DU9V-$[
MJYM4444AA1110`4444`%%%%`!1110`4444`%%%%`'SC\9T5?B%(57!>UB)QW
M/(_H*]&^%/@0^'--_M;48@-4NT&U6',$9YV^S'J?P%:5UX%35?B2?$>HJCVE
MO!&MM$3G?(,_,P]!V'<_2NVKKJ5[TU3CVU.>%'WW-A1117(=`4444`%%%%`!
:1110`4444`%%%%`!1110`4444`+1110!_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
